Neuralink still on track for first human trials by end of 2022

Elon Musk shared a few updates on Neuralink, including that the company is still on track for human trials by the end of 2022.

In February 2021, Musk shared that Neuralink was working “super hard” to make its brain implant safe. He also stated that Neuralink was closely communicating with the FDA to start initial human trials later that year. However, 2021 passed with no human trials. Earlier this year, Neuralink opened jobs for a Clinical Trial Director and Clinical Trial Coordinator, which suggested that the company is closer to testings its device on humans.



Recently, Musk noted that Neuralink might be able to address morbid obesity. The first time Musk broached the topic was during his TED interview with Chris Anderson. He told Anderson that Neuralink would focus on solving brain and spinal injuries within the next decade.

“We’re working on bridging broken links between brain & body. Neuralinks in motor & Sensory cortex riding past weak/broken links in neck/spine to Neuralinks in spinal cord should theoretically be able to restore full body functionality,” Elon Musk said in response to a Teslarati article.

Musk also told Anderson that the Neuralink device could address health conditions like morbid obesity in the long run. Professor Andrew Jackson from Newcastle University — and an expert in neural interfaces — noted that Musk’s claims about Neuralink are probable. Jackson specifically stated that Neuralink implants are less invasive than other morbid obesity treatments.